Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
DNLI on Nasdaq
There are no Buy or Sell transactions made by Marc Tessier-Lavigne since 11/23/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1.88M |
$38.3M |
$20.39 |
May 31, 2024 |
Direct |
|
|
| Common Stock |
79.2K |
$1.61M |
$20.39 |
May 31, 2024 |
The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
|
|
| Common Stock |
78.8K |
$1.61M |
$20.39 |
May 31, 2024 |
The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
|
|
| Common Stock |
78.8K |
$1.61M |
$20.39 |
May 31, 2024 |
The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
|
|
| Stock Option (right to buy) |
17.9K |
|
|
May 31, 2024 |
Direct |
Common Stock |
|
Transactions reported by Marc Tessier-Lavigne for Denali Therapeutics Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.